|
|
Our Products
Eisai Inc. is a human health care (hhc) company that seeks to discover and develop innovative therapies that can satisfy unmet medical needs and contribute to the health and well being of people worldwide. Our hhc mission means that we regard patients and their families as the most important participants in the health care process and we are dedicated to improving their lives.
We have three products on the U.S. market. Our first pharmaceutical product, a treatment for Alzheimer's disease, was launched in early 1997. Currently the most widely prescribed Alzheimer's treatment in the world, the drug was discovered by Eisai Co., Ltd. and developed by Eisai Inc. and is co-promoted with Pfizer Inc.
We launched our second product, for certain gastrointestinal disorders, in 1999. Discovered by Eisai Co., Ltd. and developed by Eisai Inc., we co-promote the product with Janssen Pharmaceutica Inc.
 Printer Friendly Version
|
|
